Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy (Diabetes)
Sponsor: |
Massachusetts General Hospital |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAU2206 |
U.S. Govt. ID: |
NCT05476276 |
Contact: |
Jorge Cabrera, CRC: 212-305-6035 / jec2273@cumc.columbia.edu |
The purpose of this study is to Assess Treatments for Painful Diabetic Peripheral Neuropathy (PDPN). To be in this study you must have type II Diabetes Mellitus, PDPN, must be 18 years of age or older, and be able to stop taking some of your current pain medications including pills, creams, patches, marijuana, cannabidiol (CBD) oil, etc. Acetaminophen (commonly known as Tylenol) is the only allowable pain medication other than the study drug.
Investigator
Thomas Brannagan, MD
Are you 18 years of age and older? |
Yes |
No |
Are you diagnosed with Type II diabetes mellitus with painful diabetic peripheral neuropathy? |
Yes |
No |
Are you on a stable treatment of diabetes for at least 3 months with no anticipated changes in medication regimen? |
Yes |
No |
Are you willing and able to comply with scheduled visits? |
Yes |
No |
Are you able to provide informed consent? |
Yes |
No |